Angpt2 has been described as surrogate of disease severity in clinical acute liver failure 65 and its relative upregulation (versus Angpt1) in murine acute-on-chronic-liver failure mediates hepatocyte dysfunction and disease via CCAAT/enhancer binding protein-β 50. Here, ANGPT2 is linked to acute-on-chronic liver failure.